Dr. Natalie Dean is Assistant Professor in the Department of Biostatistics and Bioinformatics at Emory University, Rollins School of Public Health, with a joint appointment in the Department of Epidemiology. She completed her Master’s degree and PhD in biostatistics at Harvard University. She conducted postdoctoral work at the University of Florida in the Center for Statistics and Quantitative Infectious Diseases. During the COVID-19 pandemic, Dr. Dean has received wide praise for her public engagement, which includes op-eds published in the New York Times, Washington Post, and Stat News on the topic of vaccination and vaccination studies.


  • Principal Investigator, NIH/NIAID R01 grant on vaccine study design for emerging pathogens
  • Member, R&D Blueprint for Action to Prevent Epidemics – clinical trials working group, World Health Organization, 2016-Present
  • Member, HIV Resistance Network Monitoring and Surveillance Working Group, World Health Organization, 2018-Present
  • Advisory Board, COVID Tracking Project, The Atlantic, 2020-2021
  • Provost’s Excellence Award for Assistant Professors, University of Florida, 2020
  • Assistant Professor, Department of Biostatistics, University of Florida, 2017-2021
  • Consultant, HIV Department, World Health Organization, 2014-2015


  • Methods to evaluate the effectiveness of vaccines targeting emerging infectious diseases
  • Flexible and responsive clinical trial designs
  • Integrating modeling into clinical trial planning
  • Observational studies for vaccines
  • Statistical properties of the test negative design
  • Diseases: Chikungunya, COVID-19, dengue, Ebola, HIV/AIDS, Zika


Back to People